Global therapeutic monoclonal antibodies drug market size was valued at USD 175.3 billion in 2024. The market is projected to grow from USD 195.1 billion in 2025 to USD 415.5 billion by 2032, exhibiting a CAGR of 11.0% during the forecast period. Therapeutic monoclonal antibodies (mAbs) are laboratory-engineered proteins designed to bind to specific targets, such as cancer cells or...